Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2020

Open Access 01-12-2020 | Acute Kidney Injury | Research

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis

Authors: Jia-Jin Chen, Chih-Hsiang Chang, Yen-Ta Huang, George Kuo

Published in: Critical Care | Issue 1/2020

Login to get access

Abstract

Background

The use of the furosemide stress test (FST) as an acute kidney injury (AKI) severity marker has been described in several trials. However, the diagnostic performance of the FST in predicting AKI progression has not yet been fully discussed.

Methods

In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched the PubMed, Embase, and Cochrane databases up to March 2020. The diagnostic performance of the FST (in terms of sensitivity, specificity, number of events, true positive, false positive) was extracted and evaluated.

Results

We identified eleven trials that enrolled a total of 1366 patients, including 517 patients and 1017 patients for whom the outcomes in terms of AKI stage progression and renal replacement therapy (RRT), respectively, were reported. The pooled sensitivity and specificity results of the FST for AKI progression prediction were 0.81 (95% CI 0.74–0.87) and 0.88 (95% CI 0.82–0.92), respectively. The pooled positive likelihood ratio (LR) was 5.45 (95% CI 3.96–7.50), the pooled negative LR was 0.26 (95% CI 0.19–0.36), and the pooled diagnostic odds ratio (DOR) was 29.69 (95% CI 17.00–51.85). The summary receiver operating characteristics (SROC) with pooled diagnostic accuracy was 0.88. The diagnostic performance of the FST in predicting AKI progression was not affected by different AKI criteria or underlying chronic kidney disease. The pooled sensitivity and specificity results of the FST for RRT prediction were 0.84 (95% CI 0.72–0.91) and 0.77 (95% CI 0.64–0.87), respectively. The pooled positive LR and pooled negative LR were 3.16 (95% CI 2.06–4.86) and 0.25 (95% CI 0.14–0.44), respectively. The pooled diagnostic odds ratio (DOR) was 13.59 (95% CI 5.74–32.17), and SROC with pooled diagnostic accuracy was 0.86. The diagnostic performance of FST for RRT prediction is better in stage 1–2 AKI compared to stage 3 AKI (relative DOR 5.75, 95% CI 2.51–13.33).

Conclusion

The FST is a simple tool for the identification of AKI populations at high risk of AKI progression and the need for RRT, and the diagnostic performance of FST in RRT prediction is better in early AKI population.
Appendix
Available only for authorised users
Literature
1.
Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12–20.PubMedCrossRef
2.
Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730.PubMedPubMedCentral
3.
Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018;44(3):323–36.PubMedPubMedCentralCrossRef
4.
Zhang A, Cai Y, Wang PF, Qu JN, Luo ZC, Chen XD, et al. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care. 2016;20:41.PubMedPubMedCentralCrossRef
5.
Chang CH, Yang CH, Yang HY, Chen TH, Lin CY, Chang SW, et al. Urinary biomarkers improve the diagnosis of intrinsic acute kidney injury in coronary care units. Medicine (Baltimore). 2015;94(40):e1703.CrossRef
6.
Chen JJ, Fan PC, Kou G, Chang SW, Chen YT, Lee CC, et al. Meta-analysis: urinary calprotectin for discrimination of intrinsic and prerenal acute kidney injury. J Clin Med. 2019;8(1).
7.
Jia HM, Huang LF, Zheng Y, Li WX. Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: a meta-analysis. Crit Care. 2017;21(1):77.PubMedPubMedCentralCrossRef
8.
Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17(5):R207.PubMedPubMedCentralCrossRef
9.
McMahon BA, Koyner JL, Novick T, Menez S, Moran RA, Lonze BE, et al. The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation. Biomarkers. 2018;23(1):61–9.PubMedCrossRef
10.
Udomkarnjananun S, Townamchai N, Iampenkhae K, Petchlorlian A, Srisawat N, Katavetin P, et al. Furosemide stress test as a predicting biomarker for delayed graft function in kidney transplantation. Nephron. 2019;141(4):236–48.PubMedCrossRef
11.
Borasino S, Wall KM, Crawford JH, Hock KM, Cleveland DC, Rahman F, et al. Furosemide response predicts acute kidney injury after cardiac surgery in infants and neonates. Pediatr Crit Care Med. 2018;19(4):310–7.PubMedCrossRef
12.
Kakajiwala A, Kim JY, Hughes JZ, Costarino A, Ferguson J, Gaynor JW, et al. Lack of furosemide responsiveness predicts acute kidney injury in infants after cardiac surgery. Ann Thorac Surg. 2017;104(4):1388–94.PubMedCrossRef
13.
McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM. And the P-DTAG, et al. preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388–96.PubMedCrossRef
14.
Elsaegh HKNY, Elsayed HE, Elbasha AM. The role of furosemide stress test in the prediction of severity and outcome of sepsis-induced acute kidney injury. J Egypt Soc Nephrol Transplant. 2018;18:86–95.CrossRef
15.
Lumlertgul N, Peerapornratana S, Trakarnvanich T, Pongsittisak W, Surasit K, Chuasuwan A, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22(1):101.PubMedPubMedCentralCrossRef
16.
Diana Vega Martínez GAÁ, Iñiguez JSC, Lozano LEC, Gil FCE. Precisión diagnóstica de prueba de estrés con furosemida para predicción de daño renal agudo severo. Rev Asoc Mex Med Crit Ter Int. 2016;30(4):230–4.
17.
Matsuura R, Komaru Y, Miyamoto Y, Yoshida T, Yoshimoto K, Isshiki R, et al. Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels. Ann Intensive Care. 2018;8(1):8.PubMedPubMedCentralCrossRef
18.
Elizabeth Pérez-Cruz AM-C, José Manuel Conde-Mercado,Eugenia Méndez-Calderillo. Comparación de la prueba de estrés con furosemida y biomarcadores séricos como predictores de la lesión renal aguda. Rev Hosp Jua Mex 2017;84(4):196–202.
19.
Rewa OG, Bagshaw SM, Wang X, Wald R, Smith O, Shapiro J, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: a multicenter, prospective, observational study. J Crit Care. 2019;52:109–14.PubMedCrossRef
20.
Saber HMMW, Khaled H, Awad MA. Furosemide stress test, a novel assessment tool for tubular function in critically ill patients with acute kidney injury: potential therapeutic and prognostic values. Res Opin Anesth Intensive Care. 2019;6:273–81.CrossRef
21.
Sakhuja A, Bandak G, Barreto EF, Vallabhajosyula S, Jentzer J, Albright R, et al. Role of loop diuretic challenge in stage 3 acute kidney injury. Mayo Clin Proc. 2019;94(8):1509–15.PubMedCrossRef
22.
R Vairakkani PAG, M Edwin Fernando, N D Srinivasa Prasad, S Sujit, K Thirumal Valavan, C Hariharan. Furosemide stress test to predict the severity of acute kidney injury. Indian J Nephrol. 2019;29(Suppl S1):S24-S5.
23.
L Venugopal RP, S Sreedhar, S Krishna Kumar, Arun Kumar Donakonda. Frusemide stress test to predict acute kidney injury progression and dialysis requirement: a prospective study. Indian J Nephrol. 2019;29(Suppl S1):S46-S7.
24.
mada: meta-analysis of diagnostic accuracy. R package version 0.5.9. Philipp Doebler hCR-popm.
25.
Section 2: AKI Definition. Kidney Int Suppl (2011). 2012;2(1):19–36.
26.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.PubMedPubMedCentralCrossRef
27.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.PubMedCrossRef
28.
29.
Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.PubMedCrossRef
30.
Arends LR, Hamza TH, van Houwelingen JC, Heijenbrok-Kal MH, Hunink MG, Stijnen T. Bivariate random effects meta-analysis of ROC curves. Med Decis Mak. 2008;28(5):621–38.CrossRef
31.
32.
Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26(8):2023–31.PubMedPubMedCentralCrossRef
33.
Danielle L. Davison, Ermira Brasha-Mitchell, Jay L. Koyner, Katrina Hawkins, Divya Chalikond , Michael G. Seneff, Lakhmir S. Chawla. The furosemide stress test in combination with urinary biomarkers to predict the progression and severity of acute kidney injury. Am J Kidney Dis 2014;63(5):B42.
34.
Penk J, Gist KM, Wald EL, Kitzmiller L, Webb TN, Li Y, et al. Furosemide response predicts acute kidney injury in children after cardiac surgery. J Thorac Cardiovasc Surg. 2019;157(6):2444–51.PubMedCrossRef
35.
Vargas R, Cuevas J, Lopez E. Furosemide in the early diagnosis of acute renal insufficiency in the newborn infant. Bol Med Hosp Infant Mex. 1977;34(6):1317–30.PubMed
36.
Kalra SSA, Narayan K, Gupta R. Use of furosemide stress test for edema control and predicting acute kidney injury in children with nephrotic syndrome. Indian Journal of Child Health. 2017;4(4):488–91.
37.
Palma I SY, Kabagambe S, Perry A, Palma I, Sageshima J, Perez R. The use of a furosemide stress test (FST) for assessment of discarded deceased donor kidneys in an ex-vivo normothermic perfusion model. [abstract]. Am J Transplant. 2017;17(suppl 3):A158.
38.
Baek SM, Brown RS, Shoemaker WC. Early prediction of acute renal failure and recovery. II. Renal function response to furosemide. Ann Surg. 1973;178(5):605–8.PubMedPubMedCentralCrossRef
39.
Amrita S. Pandit CP, FACS, Eugene Fernandes. Response to furosemide as marker of acute kidney injury in post-operative CABG patients. Journal of the American College of Surgeons. 2011;213(3):S46.
40.
Rivero J, Rodriguez F, Soto V, Macedo E, Chawla LS, Mehta RL, et al. Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease. BMC Nephrol. 2020;21(1):87.PubMedPubMedCentralCrossRef
41.
J. Kataoka YF, Y. Norisue, S. Fujitani. Does the response in urine output to a small dose of furosemide predict organ failure after achievement of negative fluid balance in acute respiratory failure? The interim analysis Intensive Care Medicine Experimental 2017;5(Suppl 2):44.
42.
van der Voort PH, Boerma EC, Pickkers P. The furosemide stress test to predict renal function after continuous renal replacement therapy. Crit Care. 2014;18(3):429.PubMedPubMedCentralCrossRef
43.
Rivera SGSD, Beltrán MM, Peniche MKG, Gutiérrez JÁA, Calyeca SMV. Furosemide stress test to predict success or failure to remove continuos slow renal replacement therapy in acute renal injury. Rev Asoc Mex Med Crit y Ter Int. 2018;32(2):85–92.
44.
Arkhipov VV, Papaian AV, Rivkin AM, Levicheva OV. [Functional furosemide loading test. Practical use in children with kidney diseases]. Klin Lab Diagn. 2001(3):20–4, 33.
45.
Arifianto H, Wasyanto T, Purwanto B. Acute kidney injury diagnosis in acute heart failure, does furosemide stress test make sense? Eur Heart J, Supplement 2017;19(Supplement E):E20-E1.
46.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
47.
Mariano F, Mella A, Vincenti M, Biancone L. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug. J Nephrol. 2019;32(6):883–93.PubMedCrossRef
48.
49.
Schmidt C, Hocherl K, Schweda F, Kurtz A, Bucher M. Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol. 2007;18(4):1072–83.PubMedCrossRef
50.
Kunin M, Holtzman EJ, Melnikov S, Dinour D. Urinary organic anion transporter protein profiles in AKI. Nephrol Dial Transplant. 2012;27(4):1387–95.PubMedCrossRef
51.
Krzych LJ, Czempik PF. Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials. Ann Intensive Care. 2019;9(1):85.PubMedPubMedCentralCrossRef
52.
Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Group NM-aI. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012–24.PubMedCrossRef
53.
Greenberg JH, Zappitelli M, Jia Y, Thiessen-Philbrook HR, de Fontnouvelle CA, Wilson FP, et al. Biomarkers of AKI progression after pediatric cardiac surgery. J Am Soc Nephrol. 2018;29(5):1549–56.PubMedPubMedCentralCrossRef
54.
Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190–9.PubMedCrossRef
55.
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122–33.PubMedCrossRef
56.
Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431–42.PubMedCrossRef
57.
Chen JJ, Lee CC, Kuo G, Fan PC, Lin CY, Chang SW, et al. Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis. Ann Intensive Care. 2020;10(1):30.PubMedPubMedCentralCrossRef
58.
Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016;42(3):224–37.PubMedCrossRef
59.
Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 1987;32(2):198–203.PubMedCrossRef
60.
Phakdeekitcharoen B, Boonyawat K. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol. 2012;13:92.PubMedPubMedCentralCrossRef
61.
Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care. 2014;29(2):253–9.PubMedCrossRef
Metadata
Title
Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis
Authors
Jia-Jin Chen
Chih-Hsiang Chang
Yen-Ta Huang
George Kuo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-02912-8

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue

Letter

Walkie talkies to aid health care workers’ compliance with personal protective equipment in the fight against COVID-19

Research

Gravitational distribution of regional opening and closing pressures, hysteresis and atelectrauma in ARDS evaluated by electrical impedance tomography

Review

Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance

Letter

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents

Research Letter

Liver injury in critically ill patients with COVID-19: a case series

Research

Energy transmission in mechanically ventilated children: a translational study